1 – 10 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments
- 2017
- BELIS : safety and tolerability of at home administration of trastuzumab (Herceptin (R)) subcutaneous for the treatment of patients with HER2-positive early breast cancer
- An accessible proteogenomics informatics resource for cancer researchers
- BRCA2 hypomorphic missense variants confer moderate risks of breast cancer
- 2016
- Selective cross-cohort discovery of transcriptional mechanisms presiding over high-risk neuroblastoma subtype state maintenance
- Eradication of neuroblastoma by suppressing the expression of a single long noncoding RNA
- BRD4 inhibition improves the efficacy of ABT-199 in T-cell acute lymphoblastic leukemia
- BRD4 inhibition improves the efficacy of ABT-199 in T-cell acute lymphoblastic leukemia
- M-CSF and GM-CSF receptor signaling differentially regulate monocyte maturation and macrophage polarization in the tumor microenvironment
- Tissue factor induced by epithelial-mesenchymal transition triggers a procoagulant state that drives metastasis of circulating tumor cells